drugset / Trial / NCT07215767

Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice

NCT07215767

Phase 3 Active not recruiting 688 enrolled HALEON
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this clinical study is to demonstrate the superior antihypersensitivity efficacy of a novel stannous fluoride (SnF2) and potassium nitrate (KNO3) dentifrice (Investigational Product), compared to SnF2 only, KNO3 only and Vehicle dentifrices, after 8 weeks twice daily use.

Timeline

Start
2025-09-16
Primary completion
2026-08
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Potassium Nitrate Other / unclassified Topical
Comparator stannous fluoride Small molecule Topical

Indications